The US Human Rabies Immunoglobulin Market is witnessing steady growth due to the country's well-established post-exposure prophylaxis protocols, advanced healthcare infrastructure, and increasing awareness of rabies prevention. Healthcare providers continue to utilize human rabies immunoglobulin as a critical component of emergency treatment following potential rabies exposure. Ongoing...